Tecan Group (SIX Swiss Exchange: TECN), a global provider of automated laboratory instruments and solutions, has placed 650,000 new registered shares with a par value of CHF 0.10 each in a private placement by way of an
The insurer Zurich Switzerland, a Swiss subsidiary of the Zurich Insurance group, has acquired a 25% stake in the share capital of Brokerbusiness.ch., an insurtech start-up that operates a digital insurtech
Baker McKenzie advised Amsterdam-based Keesing Media Group (Keesing) on the acquisition of the Swiss Küng Group. The deal will enable Keesing to to strengthen its European market presence and develop a stronger foothold in
Holcim Finance (Luxembourg) completed its issuance of EUR 1 billion in aggregate principal amount of 0.500 per cent. Guaranteed Notes due 2030 under its Euro Medium Term Note Programme. The notes are guaranteed by Holcim, the holding company
Allgemeine Baugenossenschaft Zürich (ABZ), a non-profit housing cooperative, launched and priced its issuance of CHF 120 million total nominal amount of 0.25% Sustainability Bonds 2021-2031. The bonds have been offered in full compliance with the Financial
Invesco Physical Markets Public Limited Company listed a new physical gold exchange-traded product (ETP) on SIX Swiss Exchange, on 27th August, 2021. Lenz & Staehelin assisted Invesco with all Swiss regulatory aspects for the listing
The Deutsche Börse Group, an international exchange organisation and innovative market infrastructure provider, acquires a majority of the shares in Crypto Finance, a Swiss crypto broker and asset manager. Through the acquisition, Deutsche Bö
EnBiotix, a Boston-based biotech company focused on rare diseases, is merging with Swiss oncology and antimicrobial resistance-focused company Polyphor. A merger agreement under which Polyphor will use all of EnBiotix’s outstanding share capital in
Walder Wyss has acted as advisor to Sleepiz in the completion of its CHF 4.4 million Series A financing round. The newly raised capital will support Sleepiz expansion of its portfolio to chronic respiratory disease monitoring.
Norres, a portfolio company of Triton Smaller Mid-Cap Fund I, acquired the Baggerman Group. The parties have agreed not to disclose the purchase price. The Baggerman Group, headquartered in Roermond, Netherlands, is a specialist
